Technical Analysis and Quality Control of Human c-Met Gene Amplification Detection Kit (Fluorescence In Situ Hybridization)

Basic Principles of Fluorescence In Situ Hybridization

The Human c-Met Gene Amplification Detection Kit (Fluorescence In Situ Hybridization) is based on the principle of complementary hybridization between fluorescently labeled nucleic acid probes and target DNA sequences. Under denaturing conditions, probes labeled with different fluorophores bind to the c-Met gene and the corresponding centromeric region in the sample to be tested. The number and distribution of signals are observed under a fluorescence microscope to determine the gene amplification status. This technique offers advantages such as accurate spatial localization and direct analysis on tissue sections, and is commonly used for the detection of paraffin-embedded tumor samples.

Probe Design and Specificity Validation

The core of the kit lies in probe design. Generally, the c-Met gene probe is required to cover key regions of the full gene length, while a centromeric reference probe (such as CEP7) is included to correct for chromosomal numerical abnormalities. During the research and development stage, probe specificity must be validated using normal lymphocyte karyotypes to ensure the absence of nonspecific cross-hybridization. In the production process, probe purity, labeling efficiency, and fluorescence intensity consistency must be strictly monitored, and each batch must undergo standard sample testing before release.

Detection Workflow and Common Key Points

The standard detection workflow includes: section preparation, pretreatment (deparaffinization, protease digestion), denaturation, hybridization, washing, counterstaining, and signal interpretation. Key operational considerations include: section thickness is generally controlled at 4–5 μm; protease digestion time should be optimized according to tissue type, as excessive digestion can lead to loss of target DNA; hybridization temperature and duration must be set strictly according to the kit instructions, with a common hybridization temperature of 37°C and a duration of 16–20 hours. The stringency of the washing steps directly affects background signal; washing with 0.3% NP-40/SSC solution at 73°C for 2 minutes is recommended.

Quality Control and Result Interpretation

Each experiment should include a positive control (a cell line with known c-Met amplification) and a negative control (normal tissue). For interpretation, at least 50 tumor cells should be counted, and the numbers of red (c-Met) and green (CEP7) signals should be recorded. Generally, a c-Met/CEP7 ratio ≥2.0 is defined as amplification-positive. In cases of ambiguous signals, excessive overlap, or high background, the experiment should be repeated. Laboratories should establish internal quality control procedures and regularly participate in external quality assessment programs.

Summary

The Human c-Met Gene Amplification Detection Kit (Fluorescence In Situ Hybridization), as an important tool in tumor molecular pathology, has been widely validated for its technical maturity and stability. Standardized operating procedures and strict quality control are essential requirements for obtaining reliable results.